Genedesign

Ibaraki, Japan Founded: 2000 • Age: 26 yrs Acquired By Ajinomoto OmniChem
Nucleic acid development and manufacturing services are provided.
Request Access

About Genedesign

Genedesign is a company based in Japan founded in 2000 was acquired by Ajinomoto OmniChem in December 2016.. Genedesign operates in a competitive market with competitors including Avecia, RiboBio, Liberate Bio, Lerna Biopharma and Shanghai Rui Platinum Biotechnology, among others.

  • Headquarter Ibaraki, Japan
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
    Ajinomoto

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    Ajinomoto OmniChem

    (Dec 09, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Genedesign

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Genedesign

Genedesign has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Ajinomoto and Ajinomoto OmniChem. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Multi-category food and beverage products are manufactured globally.
Founded Year Domain Location
Global supplier of pharmaceutical APIs, fine chemicals, and sustainable products.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Genedesign

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Genedesign

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Genedesign Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Genedesign

Genedesign operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avecia, RiboBio, Liberate Bio, Lerna Biopharma and Shanghai Rui Platinum Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
CDMO specializing in oligonucleotide production and complex small molecule synthesis
domain founded_year HQ Location
Developer of oligonucleotides
domain founded_year HQ Location
Contract manufacturing for tissue-specific nucleic acid therapeutics is provided.
domain founded_year HQ Location
Develops nucleic acid therapeutics using chemistry and biological insights for effective treatments.
domain founded_year HQ Location
Provider of drug research and development services
domain founded_year HQ Location
Research and development of multifunctional sugars is conducted.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Genedesign

Frequently Asked Questions about Genedesign

When was Genedesign founded?

Genedesign was founded in 2000.

Where is Genedesign located?

Genedesign is headquartered in Japan. It is registered at Ibaraki, Japan.

What does Genedesign do?

Genedesign was founded in 2000 and is based in Ibaraki, Japan, within the biotechnology sector. Nucleic acids for therapeutics and diagnostics are manufactured by the company. Custom synthesis services encompass DNA, RNA, BNA, siRNA, in vivo grade products, and GMP-compliant production. Solid-phase synthesis methods are employed, supporting high-mix, low-volume operations. Acquisition by Ajinomoto and its subsidiary Ajinomoto OmniChem took place in December 2016.

Who are the top competitors of Genedesign?

Genedesign's top competitors include Shandong Sanyuan Biotechnology, RiboBio and Liberate Bio.

Who are Genedesign's investors?

Genedesign has 2 investors. Key investors include Ajinomoto, and Ajinomoto OmniChem.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available